Lenalidomide Trial KO'd: A Blow to CLL Patients?Lenalidomide Trial KO'd: A Blow to CLL Patients?

Dr. Bruce Cheson discusses the clinical ramifications of the decision to halt the ORIGIN trial, which compared lenalidomide vs chlorambucil in previously untreated elderly patients with CLL. Medscape Oncology
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Hematology-Oncology Commentary Source Type: news